Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at [email protected] Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Novartis opens new radioligand therapy manufacturing facility in California

Novartis expands production of Pluvicto with addition of its largest, most advanced radioligand therapy manufacturing facility in Indianapolis

Written By Ruchika Sharma7 Jan 2024 2:30 PM IST

Basel: Novartis has announced that it has received approval from the US Food and Drug Administration (FDA) for commercial manufacturing of...

Boehringer Ingelheim, Kyowa Kirin enter into license agreement to develop fibro-inflammatory diseases treatment

Written By Ruchika Sharma7 Jan 2024 1:30 PM IST

Ingelheim: Boehringer Ingelheim and Kyowa Kirin Co., Ltd. have announced that they have entered into a license agreement to develop a novel,...

Boehringer Ingelheim to Set Up AI-Driven Drug Discovery Centre in London

Boehringer Ingelheim, 3T Biosciences enter into second partnership for cancer immunotherapies

Written By Ruchika Sharma7 Jan 2024 10:00 AM IST

Ingelheim: Boehringer Ingelheim and 3T Biosciences have announced they have entered into a new strategic collaboration and licensing agreement...

India orders new drug-making standards after overseas deaths

Written By Ruchika Sharma6 Jan 2024 4:31 PM IST

New Delhi: Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on...

Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boom

Lilly launches end to end digital healthcare experience through LillyDirect

Written By Ruchika Sharma6 Jan 2024 2:16 PM IST

Indianapolis: Eli Lilly and Company has announced LillyDirect, a new digital healthcare experience for patients in the U.S. living with...

Merck gets USFDA Priority Review for application for Keytruda plus standard of care as Perioperative treatment for Resectable Locally Advanced Head, Neck Squamous Cell Carcinoma

Merck announces Phase 3 trial initiations for 4 investigational candidates from its hematology, oncology pipeline

Written By Ruchika Sharma6 Jan 2024 12:30 PM IST

Rahway: Merck, known as MSD outside of the United States and Canada, has announced the initiation of pivotal Phase 3 trials for four of its...

Import Nod on Hold Over False Positives, Tissue Detection: CDSCO Panel Seeks More Data on Medtronics PTeye Device

Medtronic gets CE Mark for next generation Micra leadless pacing systems

Written By Ruchika Sharma6 Jan 2024 11:32 AM IST

Medtronic projects the battery life of Micra AV2 and Micra VR2 is nearly 16 and 17 years, respectively.

GSK, Pfizer resolve patent lawsuit over RSV vaccines

Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit

Written By Ruchika Sharma5 Jan 2024 4:15 PM IST

United States: A federal judge on Wednesday said Botox maker AbbVie's Allergan unit can move ahead with its lawsuit accusing Revance...

Merck seeks GLP-1 drugs with benefits beyond weight loss, says CEO

Written By Ruchika Sharma5 Jan 2024 3:36 PM IST

Rahway: Merck & Co is seeking GLP-1 treatments with benefits beyond weight loss, CEO Robert Davis said on Thursday at a conference.Newer...

USFDA Closes Inspection of Dr Reddys Srikakulam Facility with VAI Classification

Dr Reddy's Labs acquires entire MenoLabs supplements portfolio

Written By Ruchika Sharma5 Jan 2024 1:30 PM IST

Brands include MenoFit and MenoGlow probiotics, Happy Fiber and Well Rested dietary supplements, Athena's Shield menopause support supplement, and...

Lupin bags tentative USFDA nod for Dapagliflozin and Saxagliptin Tablets

Written By Ruchika Sharma5 Jan 2024 11:11 AM IST

Dapagliflozin and Saxagliptin Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes...

Esperion, Daiichi Sankyo Europe announce USD 125 million amendment to their collaboration, including resolution of pending litigation

Written By Ruchika Sharma4 Jan 2024 4:45 PM IST

Ann Arbor: Esperion Therapeutics, Inc. and Daiichi Sankyo Europe GmbH (DSE), the European headquarter organization of the Japanese pharmaceutical...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok